Evaluation of the Storage Stability of Extracellular Vesicles
May 22nd, 2019
14.1K views
Here we present a readily applicable protocol to assess the storage stability of extracellular vesicles, a group of naturally occurring nanoparticles produced by cells. The vesicles are loaded with glucuronidase as a model enzyme and stored under different conditions. After storage, their physicochemical parameters and the activity of the encapsulated enzyme are evaluated.
Overview
This article presents a protocol for assessing the storage stability of extracellular vesicles, which are nanoparticles produced by cells. The vesicles are loaded with glucuronidase and stored under various conditions to evaluate their physicochemical parameters and enzyme activity.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Extracellular vesicles
Background
- Extracellular vesicles are important for therapeutic applications.
- Storage stability affects their usability.
- Glucuronidase serves as a model enzyme for evaluation.
- Comparative analysis of vesicles from different parent cells is facilitated.
Purpose of Study
- To provide a protocol for evaluating storage effects on extracellular vesicles.
- To introduce glucuronidase as an exogenous marker.
- To compare storability of vesicles derived from various cells.
Methods Used
- Asymmetric flow field flow fractionation (AF4) for purification.
- Evaluation of physicochemical parameters post-storage.
- Assessment of encapsulated enzyme activity.
- Thorough planning and execution of purification steps.
Main Results
- AF4 is a mild alternative to size exclusion chromatography.
- Less shear stress benefits sensitive compounds like glucuronidase.
- Storage conditions significantly impact vesicle stability.
- Comparative analysis reveals differences in storability among vesicles.
Conclusions
- The protocol is effective for assessing extracellular vesicle stability.
- Glucuronidase serves as a reliable marker for evaluation.
- Storage conditions must be carefully controlled for optimal results.
Frequently Asked Questions
What are extracellular vesicles?
Extracellular vesicles are nanoparticles produced by cells that play a role in intercellular communication.
Why is storage stability important?
Storage stability is crucial for the therapeutic use of extracellular vesicles, affecting their functionality.
What is glucuronidase?
Glucuronidase is an enzyme used as a model to assess the activity and stability of extracellular vesicles.
How does AF4 compare to other purification methods?
AF4 is a gentler method that reduces shear stress on sensitive compounds compared to size exclusion chromatography.
What factors affect the stability of extracellular vesicles?
Storage conditions, including temperature and duration, significantly influence the stability of extracellular vesicles.
Executive Industry Relevance
Assessing extracellular vesicle storage stability is critical for advancing therapeutic candidates toward clinical application, as degradation during storage can compromise both physicochemical integrity and functional cargo activity. This protocol enables rapid, comparative evaluation of storage conditions across diverse EV sources without requiring genetic manipulation or specialized functional assays, supporting early de-risking in EV-based drug development. By quantifying size, concentration, morphology, and surrogate enzyme activity, it provides a pragmatic first-line stability screen to inform go/no-go decisions in preclinical formulation workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of storage-induced changes in EV physicochemical properties and cargo retention to clarify stability-related risks in therapeutic hypotheses.
- Operational Value: Facilitates side-by-side comparison of EVs from different parental cells under identical storage conditions, accelerating candidate selection.
Screening & Assay Development
- Scientific Value: Generates quantitative, reproducible readouts of EV size, particle concentration, and glucuronidase activity per particle to support assay standardization.
- Operational Value: Uses AF4 purification to minimize shear stress and isolate EVs from free enzyme, improving measurement accuracy for downstream screening applications.
Translational & Preclinical Research
- Scientific Value: Links storage conditions to measurable changes in EV integrity and functional surrogate activity, informing translational risk assessment.
- Operational Value: Provides a standardized workflow for evaluating lyophilization and cold-storage impacts, supporting formulation development decisions.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, where storage stability evaluation informs lead identification by identifying conditions that preserve EV attributes prior to preclinical efficacy testing.
- Discovery Biology: Supports hypothesis testing regarding EV stability under stress conditions, enabling mechanistic de-risking of storage-related variability.
- Screening: Delivers standardized, quantitative outputs (size, concentration, enzyme activity/particle) that allow reliable comparison of EV batches across storage variables.
- Analytics: Combines nanoparticle tracking for physical parameters with fluorometric glucuronidase assay to provide correlated physicochemical and functional readouts.
- Translational Research: Connects storage outcomes to functional cargo preservation, bridging discovery and preclinical formulation science.
- Enterprise Reuse: Establishes a reusable stability assessment platform applicable to EVs from diverse cellular origins, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in EV stability, reduction of mechanistic ambiguity in storage-induced degradation, and target validation through cargo retention metrics.
- Operational Value: Standardization via AF4 purification, reproducibility in enzyme encapsulation, and scalability across EV sources.
- Strategic Value: Better go/no-go decisions in formulation development, capital efficiency by avoiding unstable candidates, and reduced late-stage biological risk.
- Portfolio Impact: Risk-adjusted prioritization of EV candidates based on storage stability profiles, enabling data-driven advancement decisions.
Implementation Considerations
- Requires expertise in EV isolation, enzyme encapsulation techniques, and AF4 or SEC purification workflows.
- Depends on access to nanoparticle tracking analyzers, plate readers for fluorometric assays, and ultracentrifugation or AF4 instrumentation.
- Necessitates standardization of saponin and glucuronidase concentrations across teams to ensure comparable activity measurements.
- Must account for variability in EV yield and purity when comparing storage effects across different cell sources.
- Limited to surrogate activity assessment; does not replace native functional assays when available.
Biopharma FAQs
Why does glucuronidase activity measurement require AF4 purification post-storage?
AF4 purification removes free glucuronidase that may contaminate EV samples after storage, preventing overestimation of encapsulated enzyme activity. This step ensures that measured fluorescence reflects only enzyme retained within EVs, providing accurate cargo retention data. Without this purification, storage-induced enzyme leakage could be misinterpreted as enhanced stability.
How does nanoparticle tracking analysis support storage stability evaluation?
Nanoparticle tracking analysis quantifies EV size and particle concentration before and after storage, enabling detection of aggregation, fragmentation, or loss of vesicles. These physicochemical changes indicate compromised stability independent of cargo retention. Combined with enzyme activity data, it provides a multidimensional stability profile.
What quantitative output enables comparison of EV storability across cell sources?
Glucuronidase activity per particle, calculated by normalizing enzyme fluorescence to EV concentration, allows direct comparison of cargo retention across different EV sources. This metric controls for variations in yield and isolates the effect of storage on functional preservation. It supports rapid screening of EVs from diverse parental cells under identical conditions.
Why are replication requirements important for cross-functional collaboration in EV storage studies?
Replication ensures that observed storage effects are consistent and not due to technical variability in isolation or assay execution. Consistent results across builds confidence in stability assessments when shared between discovery, formulation, and analytical teams. This reproducibility is essential for aligning on go/no-go decisions in EV development programs.
What statistical analysis is needed before implementing this storage stability protocol in lead selection?
Implementation requires comparison of mean glucuronidase activity per particle and EV concentration across storage conditions using appropriate statistical tests to determine significant differences. Thresholds for acceptable activity loss (e.g., <50% reduction) should be defined based on therapeutic potency requirements. These analyses inform risk-adjusted decisions about which storage conditions advance candidates to preclinical testing.
Chapters in this video
0:04
Title
0:55
Cell-Conditioned Medium (CCM) Preparation and Ultracentrifugation and Glucuronidase Encapsulation
3:22
Size-Exclusion Chromatography (SEC) Purification
4:18
Glucuronidase Assay
5:13
Extracellular Vesicle (EV) Lyophilization and Rehydration
6:19
EV Analysis After Storage
9:15
Results: Representative EV Storage Stability Evaluation
10:47
Conclusion
